The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Theratechnologies Inc closed at $0.85.

Over the last five days, shares have gained 13.33% and are currently 4.49% off of the 52-week high. Shares have outperformed the S&P TSX by 77.96% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward63.91×
  • Forward PEG290.50×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.17
Updated at previous session's close. Delayed by at least 15 minutes.


Net Profit (TTM)

Theratechnologies Inc has a net profit margin of -156.58%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedNov 30, 201411/30/2014Aug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014
Total other revenue--------
Total revenue3022
Gross profit2020
Total cost of revenue1002
Total operating expense5465
Selling / general / administrative3232
Research & development1121
Depreciation / amortization--00--
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-2-4-3-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-4-41-4
Income after tax-4-41-4
Income tax, total0000
Net income-4-41-4
Total adjustments to net income--------
Net income before extra. items-4-41-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-41-4
Inc. avail. to common incl. extra. items-4-41-4
Diluted net income-4-41-4
Dilution adjustment0000
Diluted weighted average shares61616161
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.070.02-0.06
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.06-0.070.02-0.06